Karyopharm Therapeutics (United States)

376 papers and 6.5k indexed citations i.

About

In recent decades, authors affiliated with Karyopharm Therapeutics (United States) have published 376 papers, which have received a total of 6.5k indexed citations. Scholars at this organization have produced 270 papers in Molecular Biology, 116 papers in Hematology and 108 papers in Oncology on the topics of Nuclear Structure and Function (177 papers), Multiple Myeloma Research and Treatments (67 papers) and Cancer-related Molecular Pathways (51 papers). Their work is cited by papers focused on Molecular Biology (5.0k citations), Oncology (1.9k citations) and Hematology (1.7k citations). Authors at Karyopharm Therapeutics (United States) collaborate with scholars in United States, Canada and Italy and have published in prestigious journals including Nature Communications, Journal of Clinical Oncology and Blood. Some of Karyopharm Therapeutics (United States)'s most productive authors include Sharon Shacham, Michael Kauffman, Yosef Landesman, Erkan Baloglu and William Senapedis.

In The Last Decade

Fields of papers published by authors at Karyopharm Therapeutics (United States)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Karyopharm Therapeutics (United States) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Karyopharm Therapeutics (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Karyopharm Therapeutics (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Karyopharm Therapeutics (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karyopharm Therapeutics (United States) more than expected).

Rankless by CCL
2025